ECG
EKG LAB N240
Cardiac Conduction & Dysrhythmias
Dysrhythmias: Disorders of formation or conduction of electrical impulses in the heart.
Affected by electrolytes: Sodium (Na), Potassium (K), and Calcium affect heart function.
Depolarization: The phase of contraction.
Repolarization: The phase of relaxation.
Autonomic Nervous System:
Sympathetic: Fight or flight response; increases heart rate (HR), constricts blood vessels.
Parasympathetic: Slows heart rate, causes vasodilation of vessels.
Cardiac Impulse Characteristics
Automaticity: Ability to initiate an electrical impulse; all cardiac muscle has this property (SA node should be the strongest and quickest).
Atrial fibrillation (Afib) caused by faster responses outside of the SA node.
Ventricular fibrillation (Vfib) caused by stronger impulses in ventricles.
Excitability: Ability to respond to an electrical impulse.
Conductivity: Ability to transmit electrical impulses from one cell to another.
Heart Node Functions
SA Node: 60-100 bpm.
AV Node: 40-60 bpm.
Bundle of His to Purkinje Fibers: 20-40 bpm.
Firing order: SA Node → AV Node → Bundle of His → Purkinje Fibers.
EKG Waveform Components
Components include:
R, P, P-R interval, S-T interval, Q, S, Q-T interval.
QRS Variations Analysis
Variations in QRS patterns:
R, R, R
Q, QS, S
ST Segment Abnormalities
ST Segment: Various forms include:
Isoelectric
Elevated
Depressed
Q Waves Post Myocardial Infarction (MI)
Q waves observed after inferior MI.
Lead locations: II, III, AVF.
Arrhythmias: Pathophysiology
Prompt assessment of abnormal cardiac rhythm and patient's response is critical.
Origin Disturbances:
Sinus, atrial, ventricular, junctional (AV node).
Rate Disturbances: Brady and tachyarrhythmias.
Conduction Disturbances: Heart blocks.
Arrhythmia Interpretation Process
Steps to interpret:
Determine rate.
Determine rhythm.
Check if P wave is uniform and precedes each QRS.
Ensure QRS duration is < 0.12 sec.
Confirm 1:1 P to QRS relationship.
Ensure P-R interval is consistent and < 0.20 sec.
Determining Heart Rate
Calculate number of R to R intervals in a 6-second interval and multiply by 10 to get rate per minute.
A 6-second interval equals 30 large boxes on EKG.
Assessment of Cardiac Rhythm
Use a 6-second interval to assess and interpret rhythm components:
QRS, T, P waves.
ECG Interpretation Analysis
Questions revolving around the specific rhythm depicted in the ECG.
Arrhythmias/Dysrhythmias Etiologies
Factors that can cause:
Cardiac conditions (MI, CHF, hypertrophy).
Hypoxia/ischemia.
Acid/base, electrolyte imbalances.
Drugs, alcohol, caffeine.
Emotional stress.
Metabolic conditions (e.g., hyperthyroidism).
Connective tissue disorders.
Sinus Rhythm
Basis of normal heart rhythm and dynamics.
Sinus Bradycardia
Important to determine if the patient is symptomatic or asymptomatic.
Sinus Bradycardia Clinical Associations
Occurs in response to:
Carotid sinus massage.
Hypothermia.
Increased vagal tone.
Administration of parasympathomimetic drugs.
Disease states include:
Hypothyroidism.
Increased intracranial pressure.
Obstructive jaundice.
Inferior wall MI (R coronary artery occluded).
Sinus Bradycardia Significance & Treatment
Significance: May cause hypotension with decreased cardiac output leading to syncope, angina.
Treatment Options:
Atropine administration.
Potential need for a pacemaker.
Addressing the underlying cause (Mnemonic: All Dogs Eat Pie = Atropine, Dopamine, Epinephrine, Pacemaker).
Decreased Cardiac Output (CO)
Considerations:
Signs & symptoms of decreased CO.
Assessments required by the RN.
Information needed to report to the provider.
Nursing interventions to implement.
Collaborative interventions may be necessary.
Sinus Tachycardia
Overview of significant implications and physiological response to increased HR.
Sinus Tachycardia Clinical Associations
Associated with physiological stressors:
Exercise, hypotension, hypovolemia, myocardial ischemia, CHF, anxiety, pain, anemia, fever, hyperthyroidism, hypoxia.
Sinus Tachycardia Treatment
Treatment determined by underlying causes:
Focus on the cause; beta-adrenergic blockers may be employed to reduce HR and myocardial oxygen consumption.
Sinus Tachycardia Significance
Decreased filling time leads to decreased CO; symptoms may include dizziness and hypotension.
Increased myocardial oxygen consumption commonly follows elevated HR, contributing to angina or increased infarct size in acute MI patients.
Atrial Fibrillation
Characterized by absence of P wave due to atrial vibration.
Causes:
Cardiomyopathy, pericarditis, hyperthyroidism, HTN, valvular disease, obesity, diabetes, chronic kidney disease, recent cardiac procedures, coronary artery disease.
Complication: Loss of CO leading to thromboembolic events.
Treatment Strategies: Medications, ablation, cardioversion.
Atrial Flutter
A dysrhythmia produced by a pacemaker cell other than SA node; absence of P waves results.
Premature Ventricular Contractions (PVCs)
Characteristics: Wide and atypical QRS complexes that occur prematurely from within the ventricles.
PVCs Causes and Treatments
Causes:
Hypoxia, MI, cardiomyopathy, electrolyte imbalance, excessive stimulant intake, hypertension, recreational drug use.
Treatment:
Based on signs and symptoms; if symptomatic, correct the underlying cause; antiarrhythmic therapy used rarely.
PVCs Characteristics
Conduction originating from ectopic focus in ventricles; premature QRS complex appearance (wide, unusual beats).
Terminology:
Unifocal: One ectopic source.
Multifocal: Multiple ectopic sources, varied PVC configurations.
Bigeminy: Every other beat is a PVC.
Trigeminy: Every third beat is a PVC.
Couplets: Two PVCs in succession.
Triplets: Three PVCs consecutively.
Multifocal PVCs Analysis
Assessment of various forms in PVCs (Lead II).
Group beats, couplets, ventricular tachycardia, bigeminy, trigeminy.
PVCs Clinical Associations
Associated with any condition causing myocardial ischemia; includes stimulants, hypokalemia, exercise, MI, mitral valve prolapse.
PVCs Significance
Generally benign in a normal heart; in heart disease, PVCs could reduce CO and precipitate angina and heart failure.
Indicates ventricular irritability in ischemic heart disease or acute MI.
Possible occurrence in reperfusion arrhythmias following thrombolytic therapy or coronary intervention.
PVCs Treatment
Focus on correction of underlying causes.
Hemodynamic status assessment is vital for determining drug therapy requirements (e.g., Amiodarone, Lidocaine, Beta-blockers, Procainamide).
Ventricular Tachycardia (VT)
Significant for being life-threatening.
Seen in patients without heart disease history.
May result in severe decrease in CO, leading to pulmonary edema, shock, or compromised brain circulation.
Ventricular Tachycardia Causes & Treatment
Causes:
Hypovolemia, hypoxia, acidosis, electrolyte imbalances (hypo/hyperkalemia), toxins, cardiac tamponade, MI, pulmonary embolism.
Treatment Options:
Begin chest compressions immediately.
Defibrillation and medications are key interventions.
VT Treatment Based on Pulse Status
For Pulse Palpable VT:
If nonsustained and patient is hemodynamically stable, treat with IV Amiodarone, Procainamide, or Lidocaine.
Synchronized cardioversion when drug therapy fails and patient is responsive.
For VT without a Pulse:
Treat as ventricular fibrillation; rapid defibrillation is required.
Ventricular Fibrillation (VF)
Severe derangement of heart rhythm characterized by irregular ECG patterns.
No effective contraction or cardiac output occurs.
Outcomes include unconsciousness, absence of pulse, apnea, and seizures.
If untreated, the patient may die.
VF Treatment Protocol
Immediate initiation of CPR and ACLS required, along with drug therapy and defibrillation.
Associated with sudden cardiac death due to arrhythmia.
Ventricular Tachycardia & Fibrillation References
Medscape resource: Images from ECG monitoring for VT/VF interpretation and management strategies.
Asystole
Considerations and management protocols for asystolic events in clinical practice.
Pacemaker Overview
Discussion on atrial and ventricular pacing mechanisms.
Failure to Capture
Diagnostic criteria and response strategies for failure to capture in pacing.
CPR-BLS Technique Illustration
The procedure for chin lift and bag-and-mask technique for ventilating patients needing CPR.
Defibrillation vs. Cardioversion
Explanation and illustration of the differences in technique between defibrillation in VT without a pulse and synchronized cardioversion with a pulse.
Defibrillation Protocol Summary
Detailed documentation for pre-and post-shock protocols, with specifics on patient identifiers and timing.
Cardioversion Considerations
Synchronization importance for effective cardioversion; differences in rhythms treated.
Key Reminders
A dysrhythmia reducing CO will produce symptoms.
Identify the dysrhythmia for treatment: Drugs, CPR, cardioversion, defibrillation, or pacemaker application.
Correct electrolyte abnormalities; provide supportive care; and monitor vital signs and tissue perfusion closely.